---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-019983"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2026-03-20T23:59:59+00:00"
generated_at: "2026-05-15T09:33:54.535921+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Medifast Enters Cooperation Agreement with Steamboat Capital, Nominates Two Directors, CEO to Step Down June 1, 2026

## Summary
- Medifast (MED) entered a Cooperation Agreement with Steamboat Capital Partners (beneficial owner >5%) on March 19, 2026.
- Medifast will nominate Steamboat designees Parsa Kiai and Jeff Rose as independent directors at the 2026 annual meeting on May 19, 2026.
- Existing directors Jeffrey Brown and Michael Hoer will not stand for reelection at the 2026 annual meeting.
- CEO Dan Chard will step down on June 1, 2026, remaining Chairman; President Nicholas Johnson to succeed as CEO.
- Steamboat agreed to customary standstill and voting provisions through the 2027 annual meeting.

## SEC filing metadata
- accession: 0001628280-26-019983
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2026-03-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828026019983/0001628280-26-019983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828026019983/med-20260319.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-019983
- JSON: https://secwatch.observer/filing/0001628280-26-019983.json
- Plain text: https://secwatch.observer/filing/0001628280-26-019983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.